Herein, we observed that laboratory evidence of inflammation (i.e., CRP), insulin resistance (i.e., increased TG-HDL ratio) and elevated BMI (i.e., overweight/obesity) are highly associated with cognitive impairment in individuals with PCC. Here, CRP is linked to obesity disorder.